XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Trust Common Shares
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Stockholders' Equity Attributable to Holdings
Non- Controlling Interest
Non Controlling Interest Of Discontinued Operations [Member]
Lugano
Marucci [Member]
Lugano
Lugano
Non- Controlling Interest
Primaloft
Primaloft
Non- Controlling Interest
Series A
Trust Preferred Shares
Trust Preferred Shares
Trust Preferred Shares
Accumulated Deficit
Trust Preferred Shares
Stockholders' Equity Attributable to Holdings
Series B
Trust Preferred Shares
Series C Preferred Stock [Member]
Series C Preferred Stock [Member]
Trust Preferred Shares
Trust Common Shares
Trust Common Shares
Accumulated Deficit
Trust Common Shares
Stockholders' Equity Attributable to Holdings
Noncontrolling interest           $ 116,288                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Stockholders' Equity Attributable to Noncontrolling Interest, Discontinued Operations             $ 3,836                                
Beginning balance at Dec. 31, 2020 $ 1,220,148 $ 1,008,564 $ (211,002) $ (1,456) $ 1,100,024                 $ 96,417       $ 96,504   $ 110,997      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Net income 100,901   92,464   92,464                                    
Total comprehensive loss, net 151     151 151                                    
Stock Issued During Period, Value, New Issues (18,522) (18,522)     (18,522)                                    
Option activity attributable to noncontrolling shareholders 8,513         8,496 17                                
Effect of subsidiary stock option exercise 1,222         1,222                                  
Purchase of noncontrolling interest (50,462)         (41,830)                                  
Noncontrolling Interest, Increase from Sale of Parent Equity Interest     (8,632)   (8,632)                                    
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders (1,275)         (1,275)                                  
Distribution Expense, Allocation Interests (17,289)   (17,289)   (17,289)                                    
Distributions paid                             $ (18,136) $ (18,136) $ (18,136)       $ (127,204) $ (127,204) $ (127,204)
Ending balance at Sep. 30, 2021 1,198,716 1,027,086 (289,799) (1,305) 1,039,900                 96,417       96,504   110,997      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest           7,915                                  
Less: Net income (loss) from discontinued operations attributable to noncontrolling interest 522           522                                
Noncontrolling Interest, Increase from Business Combination 68,000                   $ 68,000                        
Noncontrolling Interest, Decrease from Deconsolidation               $ (4,375)                              
Noncontrolling interest           126,619                                  
Stockholders' Equity Attributable to Noncontrolling Interest, Discontinued Operations             4,517                                
Beginning balance at Jun. 30, 2021 1,172,997 1,008,564 (270,671) 50 1,041,861                 96,417       96,504   110,997      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Net income 90,156   88,100   88,100                                    
Total comprehensive loss, net (1,355)     (1,355) (1,355)                                    
Stock Issued During Period, Value, New Issues (18,522) (18,522)     (18,522)                                    
Option activity attributable to noncontrolling shareholders 2,895         2,892 3                                
Effect of subsidiary stock option exercise 837         837                                  
Purchase of noncontrolling interest (49,090)         (40,458)                                  
Noncontrolling Interest, Increase from Sale of Parent Equity Interest     (8,632)   (8,632)                                    
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders (1,275)         (1,275)                                  
Distribution Expense, Allocation Interests (12,075)   (12,075)   (12,075)                                    
Distributions paid                             (6,045) (6,045) (6,045)       (80,476) (80,476) (80,476)
Ending balance at Sep. 30, 2021 1,198,716 1,027,086 (289,799) (1,305) 1,039,900                 96,417       96,504   110,997      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest           2,201                                  
Less: Net income (loss) from discontinued operations attributable to noncontrolling interest (145)           (145)                                
Noncontrolling Interest, Increase from Business Combination 68,000                   $ 68,000                        
Noncontrolling Interest, Decrease from Deconsolidation               $ (4,375)                              
Noncontrolling interest           158,816                                  
Stockholders' Equity Attributable to Noncontrolling Interest, Discontinued Operations             0                                
Noncontrolling interest 172,714         172,714     $ 17,175 $ 70,585   $ 0                      
Issuance of Trust preferred shares, net of offering costs                                     $ 110,997        
Stockholders' Equity Attributable to Noncontrolling Interest, Discontinued Operations             0                                
Beginning balance at Dec. 31, 2021 1,284,530 1,123,193 (314,267) (1,028) 1,111,816                 96,417       96,504   110,997      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Net income 63,282   48,355   48,355                                    
Total comprehensive loss, net (1,565)     (1,565) (1,565)                                    
Stock Issued During Period, Value, New Issues (83,889) (83,889)     (83,889)                                    
Option activity attributable to noncontrolling shareholders 8,851         8,851                                  
Effect of subsidiary stock option exercise 1,082         1,082                                  
Purchase of noncontrolling interest (1,127)         (1,127)                                  
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders (11,292)         (11,292)                                  
Distribution Expense, Allocation Interests 0                                            
Distributions paid                             (18,136) (18,136) (18,136)       (52,794) (52,794) (52,794)
Ending balance at Sep. 30, 2022 1,391,983 1,207,082 (336,842) (2,593) 1,171,565                 96,417       96,504   110,997      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest           14,927                                  
Less: Net income (loss) from discontinued operations attributable to noncontrolling interest 0                                            
Noncontrolling Interest, Increase from Business Combination 35,263                       $ 35,263                    
Noncontrolling interest           177,337                                  
Stockholders' Equity Attributable to Noncontrolling Interest, Discontinued Operations             0                                
Beginning balance at Jun. 30, 2022 1,354,846 1,185,348 (311,092) (665) 1,177,509                 96,417       96,504   110,997      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Net income 2,585   (1,774)   (1,774)                                    
Total comprehensive loss, net (1,928)     (1,928) (1,928)                                    
Stock Issued During Period, Value, New Issues (21,734) (21,734)     (21,734)                                    
Option activity attributable to noncontrolling shareholders 3,241         3,241                                  
Effect of subsidiary stock option exercise 642         642                                  
Purchase of noncontrolling interest (424)         (424)                                  
Distribution Expense, Allocation Interests 0                                            
Distributions paid                             $ (6,045) $ (6,045) $ (6,045)       $ (17,931) $ (17,931) $ (17,931)
Ending balance at Sep. 30, 2022 1,391,983 $ 1,207,082 $ (336,842) $ (2,593) $ 1,171,565                 $ 96,417       $ 96,504   $ 110,997      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                              
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest           4,359                                  
Less: Net income (loss) from discontinued operations attributable to noncontrolling interest 0                                            
Noncontrolling Interest, Increase from Business Combination 35,263                       $ 35,263                    
Noncontrolling interest $ 220,418         $ 220,418     $ 19,393 $ 80,158   $ 34,983                      
Issuance of Trust preferred shares, net of offering costs                                     $ 110,997        
Stockholders' Equity Attributable to Noncontrolling Interest, Discontinued Operations             $ 0